DK153397C - Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte derafInfo
- Publication number
- DK153397C DK153397C DK397575A DK397575A DK153397C DK 153397 C DK153397 C DK 153397C DK 397575 A DK397575 A DK 397575A DK 397575 A DK397575 A DK 397575A DK 153397 C DK153397 C DK 153397C
- Authority
- DK
- Denmark
- Prior art keywords
- arylpiperidines
- trisubstituted
- analogue
- preparation
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50358174A | 1974-09-06 | 1974-09-06 | |
US50358174 | 1974-09-06 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK397575A DK397575A (da) | 1976-03-07 |
DK153397B DK153397B (da) | 1988-07-11 |
DK153397C true DK153397C (da) | 1988-12-05 |
Family
ID=24002675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK397575A DK153397C (da) | 1974-09-06 | 1975-09-04 | Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf |
Country Status (27)
Country | Link |
---|---|
US (1) | US4081450A (fr) |
JP (3) | JPS5929588B2 (fr) |
AR (1) | AR206937A1 (fr) |
AT (1) | AT350567B (fr) |
BE (1) | BE833044A (fr) |
BG (2) | BG24950A3 (fr) |
CA (1) | CA1069901A (fr) |
CH (1) | CH625787A5 (fr) |
CS (1) | CS188237B2 (fr) |
DD (1) | DD121636A5 (fr) |
DE (1) | DE2539452A1 (fr) |
DK (1) | DK153397C (fr) |
ES (1) | ES440771A1 (fr) |
FR (2) | FR2283679A1 (fr) |
GB (1) | GB1525584A (fr) |
HU (1) | HU173057B (fr) |
IE (1) | IE41610B1 (fr) |
IL (1) | IL48003A (fr) |
NL (1) | NL7510535A (fr) |
NZ (1) | NZ178501A (fr) |
PH (2) | PH12618A (fr) |
PL (3) | PL108465B1 (fr) |
RO (1) | RO68142A (fr) |
SE (1) | SE425489B (fr) |
SU (2) | SU629875A3 (fr) |
YU (2) | YU221675A (fr) |
ZA (1) | ZA755614B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4284635A (en) * | 1978-11-29 | 1981-08-18 | Eli Lilly And Company | Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines |
IL59553A0 (en) * | 1979-03-12 | 1980-06-30 | Lilly Co Eli | Phenylmorphans,intermediates and method for their preparation |
ZA813127B (en) | 1980-05-13 | 1982-05-26 | May & Baker Ltd | A new phenylpropargylamine derivative |
CH646696A5 (de) | 1980-11-28 | 1984-12-14 | Sandoz Ag | Dibenzazepine, ihre herstellung und verwendung. |
FR2518093A2 (fr) * | 1980-12-15 | 1983-06-17 | Roussel Uclaf | Nouveaux derives de l'hydroxyphenyl tetrahydropyridine, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant |
US4931558A (en) * | 1983-09-21 | 1990-06-05 | Eli Lilly And Company | Processes for preparing intermediates of picenadol |
US4581456A (en) * | 1983-09-21 | 1986-04-08 | Eli Lilly And Company | Processes for preparing picenadol precursors and novel intermediates thereof |
US4678638A (en) * | 1985-07-24 | 1987-07-07 | Petrolite Corporation | Highly branched amino hexahydropyridines |
PH24752A (en) * | 1987-04-16 | 1990-10-01 | Lilly Co Eli | Piperidine opioid antagonists |
US5319087A (en) * | 1987-04-16 | 1994-06-07 | Eli Lilly And Company | Piperidine opioid antagonists |
EP0299549A3 (fr) * | 1987-07-09 | 1989-02-08 | Duphar International Research B.V | 3,5-Dialkyl-3-phényl-pipéridines avec une activité antagoniste des opiates |
US5250542A (en) * | 1991-03-29 | 1993-10-05 | Eli Lilly And Company | Peripherally selective piperidine carboxylate opioid antagonists |
US5270328A (en) * | 1991-03-29 | 1993-12-14 | Eli Lilly And Company | Peripherally selective piperidine opioid antagonists |
US5159081A (en) * | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
ZA9610741B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
GB9725114D0 (en) * | 1997-11-28 | 1998-01-28 | Pfizer Ltd | Treatment of pruritus |
GB9810671D0 (en) | 1998-05-18 | 1998-07-15 | Pfizer Ltd | Anti-pruritic agents |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US7045527B2 (en) * | 2002-09-24 | 2006-05-16 | Amgen Inc. | Piperidine derivatives |
DK3022180T3 (da) * | 2013-07-15 | 2022-05-23 | Coral Sunscreen Pty Ltd | Uv-absorberende sammensætninger, der omfatter samme, og anvendelser deraf |
US10519111B2 (en) | 2013-07-15 | 2019-12-31 | Coral Sunscreen Pty Ltd | UV absorbing compounds, compositions comprising same and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2892842A (en) * | 1959-06-30 | Their preparation | ||
DD87036A (fr) * | ||||
US1915334A (en) * | 1930-10-16 | 1933-06-27 | Du Pont | Fluosilicate of organic heterocyclic bases and process of making it |
US2075359A (en) * | 1930-10-16 | 1937-03-30 | Du Pont | Insecticide |
US3080372A (en) * | 1960-03-25 | 1963-03-05 | Res Lab Dr C Janssen | 1-aroylalkyl-4-arylpiperidine derivatives |
US3936468A (en) * | 1969-10-27 | 1976-02-03 | Sumitomo Chemical Company, Ltd. | Phenylbutanol derivatives |
-
1975
- 1975-01-01 AR AR260177A patent/AR206937A1/es active
- 1975-08-26 RO RO7583241A patent/RO68142A/fr unknown
- 1975-08-27 IL IL48003A patent/IL48003A/xx unknown
- 1975-08-27 NZ NZ178501A patent/NZ178501A/xx unknown
- 1975-08-28 JP JP50104476A patent/JPS5929588B2/ja not_active Expired
- 1975-08-28 CA CA234,400A patent/CA1069901A/fr not_active Expired
- 1975-08-28 IE IE1890/75A patent/IE41610B1/en unknown
- 1975-08-29 SE SE7509640A patent/SE425489B/xx not_active IP Right Cessation
- 1975-08-29 GB GB35673/75A patent/GB1525584A/en not_active Expired
- 1975-08-29 PH PH17512A patent/PH12618A/en unknown
- 1975-09-01 BG BG7500030901A patent/BG24950A3/xx unknown
- 1975-09-01 BG BG7500035934A patent/BG24802A3/xx unknown
- 1975-09-02 YU YU02216/75A patent/YU221675A/xx unknown
- 1975-09-02 SU SU752169455A patent/SU629875A3/ru active
- 1975-09-03 ZA ZA755614A patent/ZA755614B/xx unknown
- 1975-09-03 BE BE1006861A patent/BE833044A/fr not_active IP Right Cessation
- 1975-09-04 DK DK397575A patent/DK153397C/da not_active IP Right Cessation
- 1975-09-04 PL PL1975204000A patent/PL108465B1/pl unknown
- 1975-09-04 AT AT685275A patent/AT350567B/de not_active IP Right Cessation
- 1975-09-04 PL PL1975215493A patent/PL117501B1/pl unknown
- 1975-09-04 FR FR7527189A patent/FR2283679A1/fr active Granted
- 1975-09-04 PL PL1975183125A patent/PL100438B1/pl unknown
- 1975-09-04 DE DE19752539452 patent/DE2539452A1/de not_active Withdrawn
- 1975-09-05 HU HU75EI645A patent/HU173057B/hu not_active IP Right Cessation
- 1975-09-05 NL NL7510535A patent/NL7510535A/xx active Search and Examination
- 1975-09-05 CS CS756068A patent/CS188237B2/cs unknown
- 1975-09-05 CH CH1151775A patent/CH625787A5/de not_active IP Right Cessation
- 1975-09-05 DD DD188214A patent/DD121636A5/xx unknown
- 1975-09-05 ES ES440771A patent/ES440771A1/es not_active Expired
-
1976
- 1976-03-04 FR FR7606162A patent/FR2299337A1/fr active Granted
- 1976-05-27 US US05/690,767 patent/US4081450A/en not_active Expired - Lifetime
- 1976-08-10 SU SU762388315A patent/SU621316A3/ru active
-
1977
- 1977-12-15 PH PH20561A patent/PH14016A/en unknown
-
1981
- 1981-09-18 YU YU02336/81A patent/YU233681A/xx unknown
-
1983
- 1983-06-28 JP JP58118043A patent/JPS6012350B2/ja not_active Expired
-
1984
- 1984-07-24 JP JP59155134A patent/JPS6026782B2/ja not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK153397C (da) | Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
DK140430B (da) | Analogifremgangsmåde til fremstilling af 3-aryloxy-3-phenylpropylaminer eller syreadditionssalte heraf. | |
DK144010C (da) | Analogifremgangsmaade til fremstilling af 2-piperazinyl-6,7-dimethoxyquinazoliner eller syreadditionssalte deraf | |
DK149308C (da) | Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf | |
DK138992C (da) | Analogifremgangsmaade til fremstilling af 5,9beta-disubstituerede 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf | |
DK137188C (da) | Analogifremgangsmaade til fremstilling af 2-tetrahydrofurfuryl-6,7-benzomorphaner eller syreadditionssalte heraf | |
DK146592C (da) | Analogifremgangsmaade til fremstilling af n-substituerede benzensulfonamider eller syreadditionssalte deraf | |
DK157246C (da) | Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf. | |
DK149063C (da) | Analogifremgangsmaade til fremstilling af trh-analoge derivater af histidylprolinamid eller farmaceutisk acceptable syreadditionssalte deraf | |
DK144094C (da) | Analogifremgangsmaade til fremstilling af n-substituerede 3-hydroxy-8-oxamorphinaner eller syreadditionssalte deraf | |
DK153157C (da) | Analogifremgangsmaade til fremstilling af 7-alfa-aminoacyl-3-halogen-cephalosporinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
DK154950C (da) | Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf | |
DK145574C (da) | Analogifremgangsmaade til fremstilling af substituerede cyclopropylalkylaminer eller syreadditionssalte deraf | |
DK148281C (da) | Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf | |
DK141875C (da) | Analogifremgangsmaade til fremstilling af normorphinonderivater eller syreadditionssalte deraf | |
DK143197C (da) | Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf | |
DK139574B (da) | Analogifremgangsmåde til fremstilling af terpeno-phenoxy-alkylaminer eller syreadditionssalte deraf. | |
DK157021C (da) | Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf | |
DK152211C (da) | Analogifremgangsmaade til fremstilling af n-phenyl-n-(4-piperidinyl)-amider eller farmaceutisk acceptable syreadditionssalte deraf. | |
DK135574B (da) | Fremgangsmåde til fremstilling af benzylaminderivater eller fysiologisk anvendelige syreadditionssalte heraf. | |
DK156271C (da) | Analogifremgangsmaade til fremstilling af 1,2-5,6-dianhydro-3,4-di-o-acylgalactitolderivater | |
DK138540B (da) | Analogifremgangsmåde til fremstilling af benzhydryloxyalkylaminderivater eller farmaceutisk acceptable syreadditionssalte deraf. | |
DK142172C (da) | Analogifremgangsmaade til fremstilling af basisk substituerede2-alkylamino-4-phenylimidazoliner eller syreadditionssalte heraf | |
DK135500C (da) | Fremgangsmade til fremstilling af alfa1-tert.butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol eller syreadditionssalte deraf | |
DK147105C (da) | Analogifremgangsmaade til fremstilling af 4,4'-dihydroxy-3,3'-diphenylarylmethandicarboxylsyrer eller farmaceutisk acceptable salte heraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |